• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Column: With or without you – ‘ExChina’ in vogue?

September 16, 2021 by David Barret Leave a Comment

September 16, 2021

By Mike Dolan

LONDON (Reuters) – If China becomes too difficult to price in wider investment indices due to Beijing’s unfolding regulatory crackdown on some of the country’s leading companies, the emerging markets universe may see some seismic shifts.

That’s not to say there’s any rush to exit China so far – more a rethink of what, if any, investment bucket the country now falls into in the light of rapidly redefined risks.

Many investors remain positive on China despite the uncertainties surrounding the regulatory squeeze on its Big Tech firms, “common prosperity” drive and intensifying rivalry with the United States. But they acknowledge it’s becoming much more difficult to assess the risks back-to-back with other countries.

Giant asset manager BlackRock’s decision this summer to treat China as a standalone investment outside emerging and developed market indices begs a question of just how “exChina” investments perform without the world’s second largest economy.

Despite stinging criticism from veteran investor George Soros for a ‘tragic mistake” in pouring billions into China at a politically sensitive time, BlackRock recommends investors triple their strategic weightings to Chinese equities compared with the meagre stock and bond weightings in global indices.

Although the third largest country weight in MSCI’s All-Country stock index, China’s 4.05% weight lags Japan’s almost 6% and the nearly 60% for U.S. companies.

Blackrock thinks China’s weighting should be more than 10%, even though it acknowledges that the government’s corporate and market crackdowns this year – as well as the wider political standoff between Beijing and Western capitals – was likely to see uncertainties persist for some time.

Describing China as a “distinct pole” of global growth outside of developed and emerging universes, the world’s biggest money manager’s latest investment note cautioned that these clampdowns could go on for years even if at a lower intensity than in recent years.

Tactically, it said it was breaking China out of the emerging markets orbit and recommending a neutral stance on its higher overall China weightings with an overweight to its debt.

‘EXCHINA’

Given that China represents a whopping 34% weighting in MSCI’s emerging markets equity index, an “exChina” investment in EM would appear to be a very different proposition indeed.

Over the past three years, trackers of MSCI’s emerging markets exChina index have mostly underperformed indices including China. But this summer’s government activity turned the tables on that even though price/earnings valuations in the exChina index are now more expensive.

Money flows paint a different picture, however. The latest data from the Institute of International Finance show that emerging market investment inflows last month were dominated by those headed toward China – despite all the worries.

What’s more, August was the first month since March 2020 where emerging markets excluding China showed net outflows for both equity and debt.

However, and perhaps ironically given the rising geopolitical tension, Taiwan is the second highest weighting in MSCI’s emerging market index at almost 15% – with South Korea at 13%, India at 11% and Brazil at 5%.

One big question is whether “exChina” indices should be exTaiwan too. And some wonder whether emerging investors seeking to avoid all direct China risk may do well to look at re-allocating money to countries with much smaller weights.

The diverse emerging universe, as always, creates problems in aggregration. But it’s likely all these countries will be heavily influenced economically, if not politically, by developments in China regardless.

“It’s specially challenging vis-a-vis Chinese equities. It’s hard to value the regulatory hit and say it’s worth this many P/E multiples. We are yet to buy the dip there,” said Morgan Stanley’s cross-asset strategist Andrew Sheets.

“Some of the smaller EMs could benefit,” said Sheets. “Where it could be interesting is Brazil, where valuations have fallen more than most markets. Brazil is only 4-5% of MSCI EM so it won’t take too much reallocation from China.”

(by Mike Dolan, Twitter: @reutersMikeD. Additional reporting by Sujata Rao and additional charts by Aaron Jude Saldanha; Editing by Emelia Sithole-Matarise)

Source Link Column: With or without you – ‘ExChina’ in vogue?

David Barret
David Barret

Related posts:

  1. Tennis-Sabalenka defeats Mertens in straight sets in U.S. Open fourth round
  2. China’s export, import growth likely eased in Aug on COVID-19 cases, supply bottlenecks: Reuters poll
  3. Piaggio, KTM, Honda and Yamaha set up swappable batteries consortium
  4. In Buenos Aires downtown, a city seeks new lease of life after pandemic ‘iceberg’

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • “Immediate, Sustained, And Devastating” Pain: The Most Venomous Mammal Packs An Extremely Nasty Sting
  • Domestic Cats Keeping Making Hybrids. That’s A Problem, And Yes – That Includes Some Pets
  • These Strange Little Lizards Have Toxic Green Blood, And No One Knows Exactly Why
  • How Does 2-In-1 Shampoo And Conditioner Work?
  • There Are 2-Billion-Year-Old “Millennium Rocks” In A Suburb, Hundreds Of Miles From Their Primeval Home
  • “That’s A Hellfire Missile Smacking Into That UFO”: Strange Video Emerges From US UAP Hearing
  • In 40,000 Years, Voyager 1 Will Have A Close Encounter With Gliese 445
  • Abnormally Long Gamma Ray Burst Unlike Anything We’ve Seen Before Baffles Astronomers
  • Critically Endangered Shark Meat Is Being Sold In US Stores For As Little As $2.99
  • Infectious Mouth Bacteria Lurking In Artery Plaques Could Be Behind Some Heart Attacks
  • What Would You Reach If You Kept Digging Under Antarctica?
  • First Visible Time Crystals Ever Made Have Astonishing Complexity And Practical Potential
  • “Something Undeniably Special”: The Chi Cygnids, A New Five-Yearly Meteor Shower, Peak This Month
  • A 200-Meter-Tall Event We Didn’t See Sent Signals Through The Earth For Nine Whole Days
  • Why Are So Many Volcanoes Underwater?
  • In 1977, A Hybrid Was Born In A Zoo. What It Taught Us Could Save One Of The Planet’s Most Endangered Species
  • How To Park A Dangerous Asteroid So It Doesn’t Bite You Later
  • New Study Finds Evidence For What Every Parent Knows About Bluey
  • New Breakthrough Takes Plastic Garbage And Turns It Into Tool For Carbon Capture
  • NASA To Hold Press Conference About New Perseverance Rover Discovery Tomorrow
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version